| Number of cases with adverse event | Percent % |
---|---|---|
Thrombotic thrombocytopenic purpura (TTP/VITT) | 237 | 51.5% |
Acute myocardial infarction (acute MI) | 2 | .4% |
Myocarditis | 22 | 5% |
Idiopathic thrombocytopenic purpura (ITP) | 4 | .8% |
Intracranial hemorrhage (ICH) | 33 | 7% |
Disseminated intravascular coagulopathy (DIC) | 5 | 1% |
Guillian-Barre Syndrome (GBS) | 20 | 4% |
Acute transverse myelitis (ATM) | 9 | 2% |
Acute disseminated poly radiculopathy (ADPR) | 2 | .4% |
Miller Fisher syndrome (MFS) | 1 | .2% |
Acute disseminated encephalomyelitis (ADEM) | 2 | .4% |
Inflammatory myositis | 3 | .6% |
Renal complications | 41 | 9% |
Erythema nodosum (EN) | 1 | .2% |
Sarcoid reaction | 1 | .2% |
Cutaneous vasculitis | 1 | .2% |
Steven Johnson syndrome (SJS) | 1 | .2% |
Uveitis | 1 | .2% |